Status:

COMPLETED

Lenalidomide-Adriamycin-Dexamethasone (RAD) Induction Followed by Stem Cell Transplant in Newly Diagnosed Multiple Myeloma

Lead Sponsor:

Wuerzburg University Hospital

Collaborating Sponsors:

ClinAssess GmbH

Celgene Corporation

Conditions:

Multiple Myeloma

Eligibility:

All Genders

18-65 years

Phase:

PHASE2

Brief Summary

Subjects up to the age of 65 years with newly diagnosed multiple myeloma requiring treatment are eligible. Minimal pretreatment (2 cycles of chemotherapy; local irradiation; surgery) is permitted. Aft...

Eligibility Criteria

Inclusion

  • Written informed consent
  • Newly diagnosed multiple myeloma
  • Maximum of one prior systemic therapy (2 cycles)
  • Presence of CRAB criteria
  • Measurable disease parameters
  • Left ventricular ejection fraction at least 55%
  • DLCO of at least 60%
  • Adequate bone marrow function
  • Use of adequate contraception for female subjects with childbearing potential and all male subjects
  • Eligible for autologous and allogeneic stem cell transplantation
  • Bone marrow baseline sample evaluable for interphase cytogenetics

Exclusion

  • Any serious medical conditions preventing the subject from written informed consent
  • Progressive disease (PD) to any initial treatment
  • Pregnant or lactating females
  • Any condition, including the presence of laboratory abnormalities, which places the subject at unacceptable risk if he/she were to participate in the study or confounds the ability to interpret data
  • Use of any other experimental drug or therapy within 28 days of baseline
  • Preexisting neuropathy of ≥ grade 2 severity
  • Known hypersensitivity to thalidomide
  • Any prior use of lenalidomide
  • Positive for HIV or infectious hepatitis, type A, B or C after serologic testing
  • Serum creatinine despite induction therapy ≥ 2.0 mg/dL

Key Trial Info

Start Date :

June 1 2009

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

Estimated Enrollment :

146 Patients enrolled

Trial Details

Trial ID

NCT00925821

Start Date

June 1 2009

Last Update

June 28 2012

Active Locations (12)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 3 (12 locations)

1

Charité University Hospital - Virchow Klinikum

Berlin, Germany

2

Dresden University Hospital

Dresden, Germany, 01307

3

Erlangen University Hospital

Erlangen, Germany, 91054

4

Freiburg University Hospital

Freiburg im Breisgau, Germany, 79106